BioSpace News Archive

The nationally recognized litigation firm of Burns Charest LLP has been retained to represent patent attorney Zachary Silbersher in two federal lawsuits alleging that pharmaceutical companies Valeant and Allergan violated the False Claims Act by fraudulently obtaining patents for Apriso and Namenda XR / Namzaric.

Total Revenues Increase 11% to $39.1 Million Compared to $35.2 Million in Prior-year Period

Varex Imaging Corporation (Nasdaq: VREX) today announced its financial results for the third quarter of fiscal year 2019.

Anti-tumor activity observed in multiple patients in initial data from the ongoing Phase 1 study of CA-4948 in non-Hodgkin Lymphoma

Commenced enrollment of 8 patients into an ASPIRO pivotal expansion cohort to confirm the safety and efficacy profile of AT132 for the treatment of X-linked myotubular myopathy (XLMTM) at dose of 3x10

Inovio Intends to Pursue Secondary Listing on Korea Exchange (KRX)

Revenue of $134.2 million in the second quarter of 2019, an increase of 22.4%, or 23.8% in constant currency1, over the second quarter of 2018.

Joseph J. Ferra will present a corporate overview at the 2019 Wedbush PacGrow Healthcare Conference. Details are as follows:

Total Revenues Increased 7% to $534 Million

Second quarter 2019 revenue of $19.3 million, an increase of 102% over prior year period